Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L4ML
|
|||
| Former ID |
DNC009827
|
|||
| Drug Name |
N-hydroxy-6-oxo-6-phenylhexanamide
|
|||
| Synonyms |
CHEMBL95152; N-hydroxy-6-oxo-6-phenylhexanamide; SCHEMBL1521154; BDBM50114819; 6-Oxo-6-phenyl-hexanoic acid hydroxyamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H15NO3
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C(=O)CCCCC(=O)NO
|
|||
| InChI |
1S/C12H15NO3/c14-11(10-6-2-1-3-7-10)8-4-5-9-12(15)13-16/h1-3,6-7,16H,4-5,8-9H2,(H,13,15)
|
|||
| InChIKey |
XCXZDISEAMNYJL-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment. Eur J Med Chem. 2009 Jul;44(7):2868-76. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.